Search by Drug Name or NDC
NDC 82009-0035-10 escitalopram oxalate 5 mg/1 Details
escitalopram oxalate 5 mg/1
escitalopram oxalate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Quallent Pharmaceuticals Health LLC. The primary component is ESCITALOPRAM OXALATE.
MedlinePlus Drug Summary
Escitalopram is used to treat depression in adults and children and teenagers 12 years of ago or older. Escitalopram is also used to treat generalized anxiety disorder (GAD; excessive worry and tension that disrupts daily life and lasts for 6 months or longer) in adults, teenagers, and children 7 years of age and older. Escitalopram is in a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs). It works by increasing the amount of serotonin, a natural substance in the brain that helps maintain mental balance.
Related Packages: 82009-0035-10Last Updated: 06/02/2024
MedLinePlus Full Drug Details: Escitalopram
Product Information
NDC | 82009-0035 |
---|---|
Product ID | 82009-035_a92b4700-c7be-4b31-a3bd-136779914152 |
Associated GPIs | |
GCN Sequence Number | 051642 |
GCN Sequence Number Description | escitalopram oxalate TABLET 5 MG ORAL |
HIC3 | H2S |
HIC3 Description | SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRIS) |
GCN | 18975 |
HICL Sequence Number | 024022 |
HICL Sequence Number Description | ESCITALOPRAM OXALATE |
Brand/Generic | Generic |
Proprietary Name | escitalopram oxalate |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | escitalopram oxalate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 5 |
Active Ingredient Units | mg/1 |
Substance Name | ESCITALOPRAM OXALATE |
Labeler Name | Quallent Pharmaceuticals Health LLC |
Pharmaceutical Class | Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA090939 |
Listing Certified Through | 2024-12-31 |
Package
NDC 82009-0035-10 (82009003510)
NDC Package Code | 82009-035-10 |
---|---|
Billing NDC | 82009003510 |
Package | 1000 TABLET in 1 BOTTLE (82009-035-10) |
Marketing Start Date | 2023-03-01 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.04616 |
Pricing Unit | EA |
Effective Date | 2024-02-21 |
NDC Description | ESCITALOPRAM 5 MG TABLET |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 1 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis